mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |